MedPath

Stanolone

Generic Name
Stanolone
Drug Type
Small Molecule
Chemical Formula
C19H30O2
CAS Number
521-18-6
Unique Ingredient Identifier
08J2K08A3Y
Background

A potent androgenic metabolite of testosterone. Dihydrotestosterone (DHT) is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to estradiol therefore DHT is considered a pure androgenic steroid.

Clinical Trials
Related News

Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT

Early Phase 1
Terminated
Conditions
Prostate Cancer
Interventions
First Posted Date
2012-11-12
Last Posted Date
2018-07-03
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
7
Registration Number
NCT01724619
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo gel
First Posted Date
2007-06-22
Last Posted Date
2011-06-27
Lead Sponsor
University of Washington
Target Recruit Count
31
Registration Number
NCT00490022
Locations
🇺🇸

University of Washington, Seattle, Washington, United States

Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80

Phase 2
Completed
Conditions
Late Onset Hypogonadism
Hypogonadism
Low Testosterone
Interventions
First Posted Date
2005-09-14
Last Posted Date
2022-08-15
Lead Sponsor
ASCEND Therapeutics
Target Recruit Count
128
Registration Number
NCT00163566
Locations
🇺🇸

Pensacola Research Consultants, Pensacola, Florida, United States

🇺🇸

Bethesda Health Research, Bethesda, Maryland, United States

🇺🇸

Genesis Research Consultants, Longwood, Florida, United States

and more 13 locations
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy